BOYLES P W, FERGUSON J H, MUEHLKE P H
J Gen Physiol. 1951 May;34(5):493-513. doi: 10.1085/jgp.34.5.493.
That the role of thrombin in the conversion of fibrinogen to fibrin is essentially enzymatic, is established not only by the minute amounts of thrombin which are effective but also by the complete independence of fibrin yields and thrombin concentrations over a very wide range of thrombin dilutions and clotting times. The thrombin-fibrinogen reaction, in the phase beyond the "latent period" at least, seems fundamentally "first order." Technical requirements of the experiments leading to these conclusions include: (1) a highly purified (e.g. 97 per cent "clottable") fibrinogen, (2) absence of traces of thrombic impurities in the fibrinogen, (3) absence of fibrinolytic protease contaminant of the thrombin and the fibrinogen, and (4) sufficient stability of the thrombin even at very high dilutions. Four conditions affecting thrombin stability have been investigated. Fibrin yields are not significantly modified by numerous experimental circumstances that influence the clotting time, such as (1) temperature, (2) pH, (3) non-specific salt action due to electrical (ionic) charges, which alter the Coulomb forces involved in the fibrillar aggregation, (4) specific ion effects, whether clot-accelerating (e.g. Ca(++)) or clot-inhibitory (e.g. Fe(CN)(6)''''), (5) occluding (adsorptive) colloids, which have a "fibrinoplastic" action, e.g. (a) acacia and probably (b) fibrinogen which has been mildly "denatured" by salt-heating, acidification, etc. The data with which several European workers have attempted to substantiate the idea of a two-stage thrombin-fibrinogen reaction with an intermediary "profibrin" (allegedly partly "denatured") have been reanalyzed with controls which lead us to very different conclusions, viz. (1) denaturation and fibrin formation are independent; (2) partial denaturation is "fibrinoplastic" (see above); and (3) conditions of strong salinity and acid pH (5.1) usually do not completely prevent the thrombin-fibrinogen reaction but merely prolong the "latent" phase and lessen the time required for completion of essentially the same reaction (fibrin polymerization) when more favorable clotting conditions are restored. Thus, our experiments advance the modern concepts concerning the coagulation mechanisms along lines that, for the most part, agree with those of the Harvard physical chemists, and we oppose the European views concerning a two-stage reaction, "profibrin," and "the denaturase theory" of clotting.
凝血酶在纤维蛋白原转化为纤维蛋白过程中的作用本质上是酶促作用,这不仅由有效凝血酶的微量所证实,还由在非常宽的凝血酶稀释度和凝血时间范围内纤维蛋白产量与凝血酶浓度的完全独立性所证实。凝血酶 - 纤维蛋白原反应,至少在“潜伏期”之后的阶段,似乎基本上是“一级”反应。得出这些结论的实验技术要求包括:(1)高度纯化(例如97%“可凝”)的纤维蛋白原;(2)纤维蛋白原中无微量血栓杂质;(3)凝血酶和纤维蛋白原中无纤维蛋白溶解蛋白酶污染物;(4)即使在非常高的稀释度下凝血酶仍有足够的稳定性。已经研究了影响凝血酶稳定性的四个条件。纤维蛋白产量不会因许多影响凝血时间的实验条件而有显著改变,例如(1)温度;(2)pH值;(3)由于电荷引起的非特异性盐作用,这会改变纤维状聚集所涉及的库仑力;(4)特定离子效应,无论是促凝(例如Ca(++))还是抗凝(例如Fe(CN)(6)'''');(5)封闭(吸附)胶体,其具有“纤维蛋白形成作用”,例如(a)阿拉伯胶,可能还有(b)经盐加热、酸化等轻度“变性”的纤维蛋白原。几位欧洲研究人员试图用中间“前纤维蛋白”(据称部分“变性”)来证实凝血酶 - 纤维蛋白原反应分两个阶段这一观点的数据,已通过对照重新分析,这使我们得出非常不同的结论,即:(1)变性和纤维蛋白形成是相互独立的;(2)部分变性是“纤维蛋白形成性的”(见上文);(3)高盐度和酸性pH值(5.1)条件通常不会完全阻止凝血酶 - 纤维蛋白原反应,而只是延长“潜伏”期,并在恢复更有利的凝血条件时减少完成基本相同反应(纤维蛋白聚合)所需的时间。因此,我们的实验沿着在很大程度上与哈佛物理化学家的观点一致的路线推进了关于凝血机制的现代概念,并且我们反对欧洲关于两阶段反应、“前纤维蛋白”和凝血“变性酶理论”的观点。